Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.1.22ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.75ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BF.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
CH.1.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BF.7.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.4.6.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.12.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.36ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BN.1.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BQ.1.1.8ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
CH.1.1.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.2.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.1.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
CH.1.1.15ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.4 (Omicron)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.4.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.2.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.1.1.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.1.194ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.1.303ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.36.22ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.398ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
B.1.258.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
HK.16SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-4753.05China
JN.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
EK.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BQ.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BQ.1.1.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.232NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.1.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.511NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.258.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.355NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AY.5.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.289NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.121NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.356NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.6.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.98NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.384NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.157NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.515NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used